PETS: PetMed Express, Inc.
About
PetMed Express, Inc. provides markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, and generic substitutes. The company was founded in January 1996 and is headquartered in Delray Beach, FL.
Current Value
$4.541 Year Return
Current Value
$4.541 Year Return
Key Details
Market Cap
$93.60M
P/E Ratio
-83.58
1Y Stock Return
-41.21%
1Y Revenue Growth
-4.13%
Dividend Yield
12.53%
Price to Book
1.0
Strategies that include PETS
Stock's related to PETS
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| WWW | 55.86% | $1.79B | +171.57% | 1.80% |
| FARO | 52.60% | $486.17M | +40.51% | 0.00% |
| FRSH | 48.51% | $4.39B | -20.05% | 0.00% |
| UAA | 46.43% | $4.06B | +23.88% | 0.00% |
| UA | 45.45% | $3.71B | +18.70% | 0.00% |
| KAR | 44.73% | $2.09B | +31.90% | 0.00% |
| VTRS | 43.97% | $15.58B | +39.13% | 3.70% |
| CSGS | 43.24% | $1.58B | +5.75% | 2.18% |
| APP | 42.18% | $107.79B | +728.45% | 0.00% |
| ADTN | 41.48% | $627.65M | +47.76% | 0.00% |
| ZIP | 41.21% | $853.92M | -30.91% | 0.00% |
| HBI | 39.13% | $2.92B | +111.51% | 0.00% |
| IHRT | 38.24% | $348.57M | -8.85% | 0.00% |
| GPRO | 37.60% | $179.52M | -67.23% | 0.00% |
| IONQ | 37.04% | $6.04B | +126.93% | 0.00% |
| OLPX | 35.97% | $1.16B | -7.41% | 0.00% |
| FUBO | 35.85% | $474.41M | -54.49% | 0.00% |
| SPCE | 35.55% | $196.64M | -84.01% | 0.00% |
| HCAT | 35.47% | $458.79M | 0.00% | 0.00% |
| SFIX | 35.30% | $480.74M | +11.14% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| JNPR | 0.01% | $11.61B | +30.55% | 2.49% |
| RTX | 0.01% | $158.34B | +52.22% | 2.09% |
| RLMD | 0.05% | $89.92M | +1.36% | 0.00% |
| ASPS | 0.06% | $22.36M | -80.26% | 0.00% |
| JRVR | -0.06% | $168.34M | -52.25% | 4.52% |
| RYAN | -0.06% | $8.81B | +55.63% | 0.62% |
| VIRT | 0.07% | $3.17B | +110.38% | 2.60% |
| DELL | 0.07% | $99.00B | +84.60% | 1.24% |
| SPOT | -0.08% | $90.80B | +159.59% | 0.00% |
| ITOS | 0.09% | $288.62M | -19.06% | 0.00% |
| SMMT | -0.10% | $14.74B | +910.10% | 0.00% |
| COST | -0.11% | $412.13B | +62.81% | 0.49% |
| PSN | -0.12% | $10.03B | +50.06% | 0.00% |
| PEG | 0.12% | $44.89B | +40.46% | 2.63% |
| AMBC | 0.14% | $584.50M | -17.09% | 0.00% |
| INBK | -0.15% | $350.44M | +117.95% | 0.59% |
| BACK | -0.16% | $1.76M | -32.90% | 0.00% |
| MSI | 0.16% | $81.46B | +52.34% | 0.80% |
| AXP | 0.20% | $201.15B | +75.95% | 0.94% |
| X | -0.24% | $8.76B | +13.32% | 0.51% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MELI | -29.10% | $97.16B | +28.15% | 0.00% |
| XRAY | -26.35% | $3.75B | -39.08% | 3.32% |
| ACGL | -17.67% | $36.00B | +16.84% | 0.00% |
| RNR | -15.52% | $13.74B | +23.09% | 0.58% |
| KELYA | -15.26% | $504.23M | -32.54% | 2.14% |
| FTNT | -14.19% | $69.59B | +72.67% | 0.00% |
| ALTO | -14.11% | $106.54M | -39.83% | 0.00% |
| LDOS | -14.10% | $21.12B | +49.80% | 0.96% |
| SPTN | -14.03% | $615.01M | -17.44% | 4.80% |
| VITL | -13.68% | $1.32B | +142.79% | 0.00% |
| MASI | -13.34% | $8.75B | +73.22% | 0.00% |
| WRB | -13.14% | $22.94B | +29.98% | 0.69% |
| TH | -12.84% | $839.02M | -24.49% | 0.00% |
| FC | -12.71% | $468.04M | -10.51% | 0.00% |
| DT | -12.66% | $15.40B | -1.30% | 0.00% |
| YOU | -12.66% | $2.50B | +34.63% | 1.10% |
| APA | -11.84% | $8.11B | -40.14% | 4.54% |
| CDRE | -11.34% | $1.30B | +1.85% | 1.10% |
| KVYO | -11.21% | $9.29B | +24.95% | 0.00% |
| RSG | -11.16% | $66.05B | +31.79% | 1.04% |
ETF's related to PETS
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -25.10% | $388.04M | 1.43% |
| USDU | -24.59% | $201.97M | 0.5% |
| UUP | -22.54% | $309.25M | 0.77% |
| VIXY | -14.17% | $195.31M | 0.85% |
| ULST | -9.78% | $535.47M | 0.2% |
| AGZD | -9.02% | $142.76M | 0.23% |
| HIGH | -8.98% | $302.78M | 0.51% |
| EQLS | -7.47% | $76.08M | 1% |
| FMF | -7.15% | $244.61M | 0.95% |
| DBA | -6.86% | $755.88M | 0.93% |
| KMLM | -6.71% | $353.87M | 0.9% |
| FLJH | -6.13% | $74.69M | 0.09% |
| CTA | -6.09% | $350.27M | 0.78% |
| IBHD | -4.87% | $327.80M | 0.35% |
| BILZ | -4.87% | $563.02M | 0.14% |
| KRBN | -4.16% | $242.47M | 0.85% |
| BOXX | -2.62% | $4.43B | 0.1949% |
| TBLL | -2.42% | $1.92B | 0.08% |
| HEWJ | -2.33% | $347.32M | 0.5% |
| DBJP | -2.22% | $399.93M | 0.45% |
News
SeekingAlpha
PetMed Express (PETS) surged 35.8% on Nov. 7, following the online pet pharmacy's latest quarterly earnings release.
Yahoo
PetMed Express ( NASDAQ:PETS ) Second Quarter 2025 Results Key Financial Results Revenue: US$59.6m (down 16% from 2Q...
Yahoo
DELRAY BEACH, Fla., Nov. 07, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS), will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024 virtually. Sandra Campos, CEO and President, will meet with investors and present at approximately 1:45 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of the presentation will be available on the “Events & Presentations” section of PetMed’s investor relations
Yahoo
Despite a decline in revenue, PetMed Express Inc (PETS) focuses on improving margins, customer experience, and strategic marketing to drive future growth.
Yahoo
DELRAY BEACH, Fla. AP) — PetMed Express Inc. PETS) on Wednesday reported earnings of $2.3 million in its fiscal second quarter.
SeekingAlpha
PetMed Express, Inc. (NASDAQ:PETS) Q2 2025 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsReed Anderson - Investor Relations,...
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.